Interleukin 10 receptor blockade: pentavalent antimony treatment in experimental visceral leishmaniasisMURRAY, Henry W.Acta tropica. 2005, Vol 93, Num 3, pp 295-301, issn 0001-706X, 7 p.Article

Treatment of visceral leishmaniasis in 2004MURRAY, Henry W.The American journal of tropical medicine and hygiene. 2004, Vol 71, Num 6, pp 787-794, issn 0002-9637, 8 p.Article

Suppression of posttreatment recurrence of experimental visceral leishmaniasis in T-cell-deficient mice by oral miltefosineMURRAY, Henry W.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 11, pp 3235-3236, issn 0066-4804Article

Tissue granuloma structure-function in expérimental visceral leishmaniasisMURRAY, Henry W.International journal of experimental pathology. 2001, Vol 82, Num 5, pp 249-267, issn 0959-9673Article

Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis : Intracellular adhesion molecule 1-dependent and -independent regulationMURRAY, Henry W.Infection and immunity. 2000, Vol 68, Num 11, pp 6294-6299, issn 0019-9567Article

Treatment of visceral Leishmaniasis (Kala-Azar) : A decade of progress and future approachesMURRAY, Henry W.International journal of infectious diseases. 2000, Vol 4, Num 3, pp 158-177, issn 1201-9712Article

Availability of miltefosine for the treatment of kala-azar in IndiaSUNDAR, Shyam; MURRAY, Henry W.Bulletin of the World Health Organization. 2005, Vol 83, Num 5, pp 394-395, issn 0042-9686, 2 p.Article

Malaria: 30 years of experience at a New York City teaching hospitalKAMBILI, Chrispin; MURRAY, Henry W; GOLIGHTLY, Linnie M et al.The American journal of tropical medicine and hygiene. 2004, Vol 70, Num 4, pp 408-411, issn 0002-9637, 4 p.Article

Short report : Responses to Leishmania Donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthaseMURRAY, Henry W; ZHAOYING XIANG; XIAOJING MA et al.The American journal of tropical medicine and hygiene. 2006, Vol 74, Num 6, pp 1013-1015, issn 0002-9637, 3 p.Article

Drugs against leishmaniasis: a synergy of technology and partnershipsDAVIS, Antony J; MURRAY, Henry W; HANDMAN, Emanuela et al.Trends in parasitology. 2004, Vol 20, Num 2, pp 73-76, issn 1471-4922, 4 p.Article

Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18MURRAY, Henry W; TSAI, Christine W; JIANGUO LIU et al.Infection and immunity. 2006, Vol 74, Num 7, pp 4370-4374, issn 0019-9567, 5 p.Article

Visceral Leishmania donovani infection in interleukin-13^-/- miceMURRAY, Henry W; TSAI, Christine W; JIANGUO LIU et al.Infection and immunity. 2006, Vol 74, Num 4, pp 2487-2490, issn 0019-9567, 4 p.Article

Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasisMURRAY, Henry W; MONTELIBANO, Christina; PETERSON, Ron et al.The Journal of infectious diseases. 2000, Vol 182, Num 5, pp 1497-1502, issn 0022-1899Article

Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasisMURRAY, Henry W; MOREIRA, Andre L; LU, Cristina M et al.The Journal of infectious diseases. 2003, Vol 188, Num 3, pp 458-464, issn 0022-1899, 7 p.Article

Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasisMURRAY, Henry W; LU, Cristina M; BROOKS, Elaine B et al.Infection and immunity. 2003, Vol 71, Num 11, pp 6453-6462, issn 0019-9567, 10 p.Article

New Treatment Approach in Indian Visceral Leishmaniasis : Single-Dose Liposomal Amphotericin B Followed by Short-Course Oral MiltefosineSUNDAR, Shyam; RAI, M; CHAKRAVARTY, J et al.Clinical infectious diseases. 2008, Vol 47, Num 8, pp 1000-1006, issn 1058-4838, 7 p.Article

Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasisMURRAY, Henry W; FLANDERS, Kathleen C; DONALDSON, Debra D et al.Infection and immunity. 2005, Vol 73, Num 7, pp 3903-3911, issn 0019-9567, 9 p.Article

Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapyMURRAY, Henry W; LU, Christina M; MAUZE, Smita et al.Infection and immunity. 2002, Vol 70, Num 11, pp 6284-6293, issn 0019-9567, 10 p.Article

Case Report: Non-Oral Treatment with Ivermectin for Disseminated StrongyloidiasisFUSCO, Dahlene N; DOWNS, Jennifer A; SATLIN, Michael J et al.The American journal of tropical medicine and hygiene. 2010, Vol 83, Num 4, pp 879-883, issn 0002-9637, 5 p.Article

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in IndiaSUNDAR, Shyam; CHAKRAVARTY, Jaya; AGARWAL, Dipti et al.The New England journal of medicine. 2010, Vol 362, Num 6, pp 504-512, issn 0028-4793, 9 p.Article

Rapid, noninvasive diagnosis of visceral leishmaniasis in India : Comparison of two immunochromatographic strip tests for detection of anti-K39 antibodySUNDAR, Shyam; MAURYA, Radheshyam; SINGH, Rakesh K et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 1, pp 251-253, issn 0095-1137, 3 p.Article

Failure of pentavalent antimony in visceral leishmaniasis in India : Report from the center of the Indian EpidemicSUNDAR, Shyam; MORE, Deepak K; SINGH, Manoj K et al.Clinical infectious diseases. 2000, Vol 31, Num 4, pp 1104-1107, issn 1058-4838Article

Amphotericin B Treatment for Indian Visceral Leishmaniasis : Response to 15 Daily versus Alternate-Day InfusionsSUNDAR, Shyam; CHAKRAVARTY, J; RAI, V. K et al.Clinical infectious diseases. 2007, Vol 45, Num 5, pp 556-561, issn 1058-4838, 6 p.Article

Amphotericin B treatment for indian visceral leishmaniasis: Conventional versus lipid formulationsSVNDAR, Shyam; MEHTA, Himanshu; SVRESH, A. V et al.Clinical infectious diseases. 2004, Vol 38, Num 3, pp 377-383, issn 1058-4838, 7 p.Article

Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosisSAFDAR, Amar; WHITE, Dorothy A; STOVER, Diane et al.The American journal of medicine. 2002, Vol 113, Num 9, pp 756-759, issn 0002-9343, 4 p.Article